http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9170259-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad6cf02acc684e527324f91b3fe78b42
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2014-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_495812a1e2b98826957d3e7dfab9124d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0584b42fc5e4d2cac99b5620b7a0882
publicationDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9170259-B2
titleOfInvention Serological methods and diagnostic tests for syphilis antibodies
abstract A method of detecting antibodies to syphilis antigens includes providing a syphilis detection kit having a screening solid-phase platform with a screening portion coated with non-treponemal syphilis antigens. The screening portion is fabricated by initially dissolving cholesterol in an organic solvent and further diluting the dissolved cholesterol in an ethanol solution comprising cardiolipin and lecithin to form an antigen solution, permitting the antigen solution to evaporate at the screening portion and at least partially coating the screening portion with an antigen coating, and stabilizing the antigen coating into a syphilis antigen complex by overcoating the antigen coating with an overcoat solution comprising an inert protein.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015377902-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9482674-B2
priorityDate 2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8481112-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6946145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8481113-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8288153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4962046-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8101234-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE43914-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5776706-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5279935-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7335736-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8192646-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071359-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158193-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7005270-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5231035-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6921496-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5840587-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6423270-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5639620-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8639449-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8288152-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5827749-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8945827-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8034259-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5561070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071361-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5565366-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8778619-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6822000-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006171967-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4738932-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7566476-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7888043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7470379-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6815173-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54740249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5479530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11025495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684461

Total number of triples: 80.